Skip to main content
Equibles

IVA · INVENTIVA · Documents

Use IVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
3.0100 EUR -0.1350 (-4.29%) At close · Oct 5
Rebalance outlook locked
Market Cap
656.69M EUR
Shares
236.22M

INVENTIVA's financial reports and regulated publications, as filed with the market regulator, most recent first.

Type Filing Date Period Open
ESEF Annual Report 2026-04-09 2025-12-31
ESEF Annual Report 2025-04-23 2024-12-31
ESEF Annual Report 2023-03-29 2022-12-31
ESEF Annual Report 2022-03-23 2021-12-31
Showing 1–4 of 4 filings

Official financial reports

Official annual, half-year and quarterly publication attachments from DILA / AMF. These are source links, not extracted financial figures. Publication dates are not reporting periods. One publication can have multiple attachments. Source revisions remain separate; do not treat every entry as a current report. Only captured publication months are covered, and gaps may exist. Freshness covers every captured month; CheckedAt is the oldest month check.

Report catalogue coverage may be out of date.

Financial report publications from DILA / AMF — info-financière
Published (UTC)ReportTypeSource revision
2026-09-28 RFS Français · 647872_20260929 Half-year financial and audit report NEW
2026-09-28 Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update Anglais · 114816_20260928 Half-year financial and audit report NEW
2026-09-28 Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités Français · 134816_20260928 Half-year financial and audit report NEW
2025-09-29 Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update Anglais · 110286_20250929 Half-year financial and audit report NEW
2025-09-29 Inventiva publie ses résultats financiers non audités du premier semestre 2025 et fait le point sur ses activités Français · 130286_20250929 Half-year financial and audit report NEW
2025-09-28 RFS Français · 597952_20250929 Half-year financial and audit report NEW
2024-10-14 Inventiva announces Filing of 2024 Half-Year Report – Conditions for Accessing or Consulting the Report Anglais · 117202_20241014 Half-year financial and audit report NEW
2024-10-14 Inventiva publie son Rapport Financier Semestriel 2024 – Modalités de mise à disposition ou de consultation Français · 137202_20241014 Half-year financial and audit report NEW
2024-10-14 RFS 2024 Français · 557021_20241014 Half-year financial and audit report NEW
2023-11-21 Inventiva reports 2023 Third Quarter Financial Information¹ Anglais · 110578_20231121 Quarterly financial information NEW
2023-11-21 Inventiva publie ses informations financières du 3ème trimestre 2023¹ Français · 130578_20231121 Quarterly financial information NEW
2023-09-28 Inventiva reports its 2023 first-half financial results and provides a corporate update Anglais · 111726_20230928 Half-year financial and audit report NEW
2023-09-28 Inventiva publie ses résultats financiers du 1er semestre 2023 et fait un point sur ses activités Français · 131726_20230928 Half-year financial and audit report NEW
2023-09-28 RFS 30 juin 2023 Français · 507034_20230929 Half-year financial and audit report NEW
2023-07-27 Correction: Inventiva publie ses informations financières préliminaires du 1er semestre 2023¹ et fait un point sur ses activités Français · 132012_20230727 Half-year financial and audit report NEW
2023-07-27 Inventiva Reports Preliminary 2023 First-Half Financial Information¹ and Business update Anglais · 111990_20230727 Half-year financial and audit report NEW
2023-07-27 Inventiva publie ses informations financières préliminaires du 1er semestre 2023¹ et fait un point sur ses activités Français · 131990_20230727 Half-year financial and audit report NEW
2023-03-29 Inventiva reports its 2022 full-year results Anglais · 110975_20230329 Annual financial and audit report NEW
2023-03-29 Inventiva publie ses résultats annuels 2022 Français · 130975_20230329 Annual financial and audit report NEW
2023-03-29 Document d'enregistrement universel 2022 Français · 478273_20230329 Annual financial and audit report NEW
2022-11-10 Correction: Inventiva publie ses informations financières du 3ème trimestre 2022¹ Français · 136273_20221110 Quarterly financial information REC MDMKW136241_20221110.xml
2022-11-10 Inventiva reports 2022 Third Quarter Financial Information¹ Anglais · 116241_20221110 Quarterly financial information NEW
2022-11-10 Inventiva publie ses informations financières du 3ème trimestre 2022¹ Français · 136241_20221110 Quarterly financial information NEW
2022-09-22 Inventiva reports its 2022 first-half financial results and provides a corporate update Anglais · 116808_20220922 Half-year financial and audit report NEW
2022-09-22 Inventiva publie ses résultats financiers du 1er semestre 2022 et fait un point sur ses activités Français · 136808_20220922 Half-year financial and audit report NEW
2022-09-22 Rapport Financier Semestriel 30 juin 2022 Français · 458796_20220922 Half-year financial and audit report NEW
2022-07-28 Inventiva Reports 2022 First-Half Financial Information¹ Anglais · 117015_20220728 Half-year financial and audit report NEW
2022-07-28 Inventiva publie ses informations financières du 1er semestre 2022¹ Français · 137015_20220728 Half-year financial and audit report NEW
2022-05-16 Inventiva reports 2022 First Quarter Financial Information and provides clinical development update Anglais · 113760_20220516 Half-year financial and audit report NEW
2022-05-16 Inventiva publie ses informations financières du 1er trimestre 2022 et fait un point sur ses développements cliniques Français · 133760_20220516 Half-year financial and audit report NEW
2022-03-07 Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis Anglais · 119254_20220307 Annual financial and audit report REC MDMKW119248_20220307.xml
2022-03-07 Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et cedirogant dans le psoriasis Français · 139254_20220307 Annual financial and audit report NEW
2022-03-07 Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et cedirogant dans le psoriasis Anglais · 119248_20220307 Annual financial and audit report NEW
2022-02-14 Inventiva reports cash position and revenues for Full-Year 2021 Anglais · 114783_20220214 Annual financial and audit report NEW
2022-02-14 Inventiva publie sa position de trésorerie et son chiffre d’affaires pour l’exercice 2021 Français · 134783_20220214 Annual financial and audit report NEW
2021-11-10 Inventiva reports 2021 Third Quarter Financial Information Anglais · 117610_20211110 Quarterly financial information NEW
2021-11-10 Inventiva publie ses informations financières du 3ème trimestre 2021 Français · 137610_20211110 Quarterly financial information NEW
2021-09-20 Inventiva reports 2021 first half financial results and provides a corporate update Anglais · 118080_20210920 Half-year financial and audit report NEW
2021-09-20 Inventiva publie ses résultats financiers du 1er semestre 2021 et fait un point sur ses activités Français · 138080_20210920 Half-year financial and audit report NEW
2021-09-20 RFS 2021 Français · 401304_20210920 Half-year financial and audit report NEW
2021-03-15 URD 2020 Français · 377296_20210315 Annual financial and audit report NEW
2020-09-16 RFS 30 juin 2020 Français · 349505_20200916 Half-year financial and audit report NEW
2020-04-09 Rapport financier annuel 2019 Français · 334655_20200409 Annual financial and audit report NEW
2020-03-10 2019 Full-Year Results: Significant progress in NASH, MPS VI and psoriasis, and extended cash runway Anglais · 113431_20200310 Annual financial and audit report NEW
2019-11-13 Q3 2019 financial information and update on the partnership with Boehringer Ingelheim Anglais · 113463_20191113 Quarterly financial information NEW
2019-11-13 Information financière du 3ème trimestre 2019 et point sur le partenariat avec Boehringer Ingelheim Français · 133463_20191113 Quarterly financial information NEW
2019-09-25 Rapport semestriel 2019 Français · 307814_20190925 Half-year financial and audit report NEW
2018-09-27 Rapport financier semestriel au 30 juin 2018 Français · 258203_20180928 Half-year financial and audit report NEW
2017-11-07 Information financière trimestrielle / Information financière du troisième trimestre Français · 105304_20171107 Quarterly financial information NEW
2017-11-07 Quarterly financial report / Third quarter financial report Anglais · 105305_20171107 Quarterly financial information NEW

238 publication months captured between 2007-01 and 2026-10; gaps may exist. Oldest month check 2026-09-21 02:08 UTC.

Showing 1–50 of 50 publications